Élcio Piovesan

Anti-CGRP Monoclonal Antibodies in Chronic Migraine: A Position Statement of the Brazilian Academy of Headache and Orofacial Pain

Background Chronic migraine (CM) is a disabling neurological condition with high burden, common comorbidities, and a frequent profile of treatment resistance. Although there is progress in mechanism-based therapeutic approaches, such as anti-calcitonin gene-related peptide (CGRP)...